Filing Flows › Sensus Healthcare (SRTS) › R&D spending
Sensus Healthcare (SRTS) R&D spending by quarter
Sensus Healthcare's R&D spending was $1.1M in Q2 2026 (second quarter 2026), -30% from Q1 2026. Over the last 7 quarters it ranged from $1.1M (Q2 2026) to $2.6M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.1M | -30% | -25% |
| Q1 2026 | $1.6M | -16% | -39% |
| Q4 2025 | $1.9M | +3% | +21% |
| Q3 2025 | $1.8M | +24% | — |
| Q2 2025 | $1.5M | -44% | — |
| Q1 2025 | $2.6M | +67% | — |
| Q4 2024 | $1.6M | — | — |
Q2 2026 at a glance
Sensus Healthcare, Q2 2026: revenue $2.3M (-69% year over year), operating margin -138.9%, net loss $8.7M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Sensus Healthcare's R&D spending?
Sensus Healthcare's R&D spending was $1.1M in Q2 2026 (second quarter 2026), -30% from Q1 2026.
How has Sensus Healthcare's R&D spending changed?
Over the last 7 quarters it ranged from $1.1M (Q2 2026) to $2.6M (Q1 2025).